Figure 2 Cumulative proportion of patients experiencing a seizure recurrence after randomization, comparing immediate vs deferred treatment Cumulative.

Slides:

Advertisements

Similar presentations

Management Antiepileptic Drug Therapy – Goal: completely prevent seizures without causing untoward side effects Treat the underlying conditions – Reverse.

Advertisements

Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology A 14-year-old boy with lip twitching.

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.

Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Duloxetine on Pain, Function, and Quality.

Volume 16, Issue 7, Pages (July 2017)

Volume 92, Issue 2, Pages (December 2010)

Volume 386, Issue 9988, Pages (July 2015)

Volume 11, Issue 4, Pages (April 2012)

Dolutegravir versus Raltegravir in Treatment Experienced SAILING Study

Figure 1 Flow diagram of the study protocol.

Meta-analysis of randomised controlled trials

Volume 5, Issue 4, Pages (April 2006)

Volume 92, Issue 1, Pages 2-3 (July 2017)

S. Kılınç, C. Campbell Seizure - European Journal of Epilepsy

(p for noninferiority = )

Low-level laser therapy for neck pain

Figure 1 Percentages of patients with first seizure experiencing a recurrent seizure over time This graph is based on a fixed-effect pooled percentage.

Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

Seizures in the Elderly: Treatment and Special Considerations

Mean (± S.E.) change from baseline in the 6-min walk distance for bosentan (n = 21) and placebo (n = 11) groups. Mean (± S.E.) change from baseline in.

Volume 14, Issue 4, Pages (April 2015)

Early treatment after stroke for the prevention of late epileptic seizures: A report on the problems performing a randomised placebo-controlled double-blind.

Figure 2 Imaging of atherosclerotic plaque burden

Aspirin in the prevention of cancer – Author's reply

Nat. Rev. Urol. doi: /nrurol

Figure Brain MRI of the patient throughout the disease course(A) Brain MRI at the time of cerebral toxoplasmosis diagnosis (a) and after 1 month of toxoplasmosis.

Short-Bowel Syndrome Clinical Gastroenterology and Hepatology

Figure 3 JCV index changes in JCV+ patients

NIPPON Trial design: Patients undergoing percutaneous coronary intervention were randomized to short-term dual antiplatelet therapy (DAPT) (6 months; n.

Figure 2 FXTAS Rating Scale scores for case 1

Ovarian stimulation protocols for IVF: is more better than less?

Ali F. AbuRahma, MD Journal of Vascular Surgery

Figure 2 Primary and secondary outcomes reported in multiple sclerosis (MS) disease-modifying therapy (DMT) clinical trials Primary and secondary outcomes.

Figure 1 Outcomes of greatest importance to selection of a multiple sclerosis (MS) disease-modifying therapy (DMT), as defined by persons with MS and panelists.

Figure 1 Evolution of visual function after acute optic neuritis Figure shows the measurement of high-contrast visual acuity (VA) using the Early Treatment.

Figure 1 MOR103 sequential-dose trial flowchart of study population with multiple sclerosis aPatients received 2 doses of study drug before trial withdrawal.

Figure 1 8-Iso-PGF2α levels in CSF of patients with MS and controlsCSF 8-iso-prostaglandin F2α (8-iso-PGF2α) levels were estimated using an ELISA. (A)

Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin? O.A. Cornely Clinical Microbiology and.

CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.

Volume 9, Issue 4, Pages (April 2008)

Figure 1 Evolution of blood cell counts during 18-month treatment and follow-up (A) Mean white blood cell count, (B) mean lymphocyte count, (C) mean eosinophil.

Figure 4 Pattern of relapse in patients with MOG-Ab Five myelin oligodendrocyte glycoprotein antibody (MOG-Ab)–positive patients experienced a relapse,

Department of Error The Lancet Volume 369, Issue 9564, (March 2007)

Volume 13, Issue 12, Pages (December 2014)

Figure 1 Within-groups sum of squares vs number of clusters Within-groups sum of squares vs number of clusters to determine the number needed for k-means.

Figure 1 JCV serostatus JCV serostatus (A) Serostatus of 1,921 natalizumab-treated patients with multiple sclerosis, with JCV− patients shown in black.

Volume 373, Issue 9672, Pages (April 2009)

Figure 5 Pairwise correlations between selected patient-reported outcomes and performance tests in patients with MS (A) The number of pairwise correlations.

Figure 3 Longitudinal performance of 2 MS–cohabitant participant pairs on Ishihara color testing Both response speed and response accuracy are provided.

DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.

Volume 371, Issue 9618, Pages (March 2008)

Catherine M. Pound et al. Hospital Pediatrics 2017;7:

DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.

Figure 1 Annual trend in specimen type submitted as first sample for aquaporin-4 immunoglobulin G testing (serum only vs CSF only vs both) from 101,065.

Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,

Figure 1 Patterns of study retention The proportion of individuals actively participating in the study is displayed over the course of the study. Patterns.

Figure 2 Kaplan-Meier survival graphs for 10-year risks of overall and post-90-day recurrent ischemic stroke (IS) and death Kaplan-Meier survival graphs.

Figure 2 Repopulation of CD19+ cells in low and high BSA patients and calculation of the BSA Repopulation of CD19+ cells in low and high BSA patients and.

Figure 1 Peripheral blood lymphocyte counts during dose titrationB-lymphocyte (CD19+; A) and total lymphocyte (CD45+; B) counts (cells/µL) in peripheral.

Figure Meta-analysis of 9 studies of patients with attention-deficit/hyperactivity disorder (ADHD) vs controls Meta-analysis of 9 studies of patients with.

Volume 388, Issue 10042, Pages (July 2016)

Illustration of a trial design to help evaluate the clinical accuracy of a test of ischaemia. Illustration of a trial design to help evaluate the clinical.

Figure Interactive world map

Risk of MTCT of T gondii, according to gestational age at seroconversion. Risk of MTCT of T gondii, according to gestational age at seroconversion. Data.

Figure 3 Freedom from clinical disease activity during 36 months of fingolimod treatment Freedom from clinical disease activity during 36 months of fingolimod.

Acute and Chronic Seizures in Patients Older Than 60 Years

Pleurodesis for primary spontaneous pneumothorax – Authors' reply

Increased frequency and number of KLL-specific clonotypes in tumors is associated with improved MCC-specific survival. Increased frequency and number of.

Presentation transcript:

Figure 2 Cumulative proportion of patients experiencing a seizure recurrence after randomization, comparing immediate vs deferred treatment Cumulative proportion of patients with an unprovoked first seizure experiencing a seizure recurrence after randomization and comparing patients with immediate antiepileptic drug treatment vs patients with treatment deferred pending a seizure recurrence (A), and in this specific study, comparing those individuals with patients who had multiple seizures before randomization to treatment (B). Cumulative proportion of patients experiencing a seizure recurrence after randomization, comparing immediate vs deferred treatment Cumulative proportion of patients with an unprovoked first seizure experiencing a seizure recurrence after randomization and comparing patients with immediate antiepileptic drug treatment vs patients with treatment deferred pending a seizure recurrence (A), and in this specific study, comparing those individuals with patients who had multiple seizures before randomization to treatment (B). Reprinted from The Lancet (Marson et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005;365:2007–2013), © 2005, with permission from Elsevier.15 Allan Krumholz et al. Neurology 2015;84:1705-1713 © 2015 American Academy of Neurology